Authors’ Response to “Editorial: stratifying risk of adverse outcomes in cirrhosis—the Hepquant SHUNT test”

Authors’ Response to “Editorial: stratifying risk of adverse outcomes in cirrhosis—the Hepquant SHUNT test”

April 2021

Source: Alimentary Pharmacology and Therapeutics

Publication: